To check this safely, do you have any of these conditions?
Optional — answering sharpens the safety check. You can skip it; the answer below flags what's uncertain.
Can I take magnesium glycinate and ashwagandha for perimenopause sleep? I'm on an SSRI.
Question interpreted as
Magnesium for sleep
- Population
- primarily older adults with insomnia
- Comparator
- placebo or no treatment
- Time
- 3–8 weeks
- Form and dose
- varied; one 8-week trial used 500 mg elemental magnesium daily
Decision summary
What this answer means
- may modestly reduce sleep-onset latency in older adults with insomnia, but the evidence is limited and low quality; benefit for general adults or magnesium glycinate specifically is uncertain (grade C, low certainty).
- Safety constrains the action: Ashwagandha with an SSRI may carry additive sedative/serotonergic risk; evidence is limited.
- Personal applicability cannot be determined yet because the evidence-sensitive details about you are unknown.
- This action describes the general evidence only; it is not a personalized recommendation.
Evidence, safety, personal fit and action are separate judgments. Open the sections below to inspect each one.
⚠ Safety first
[why?]
This was promoted by the safety gate because the interaction edge between the intervention and an item in your context fires at moderateseverity. Safety items are ordered most-severe-first; nothing else displaces them.
[how serious?]
Possible additive or interfering effect; evidence is limited. Worth a clinician check before combining.
This case routes to a clinician because the combination touches a prescription in your context — the engine will not silently recommend it.
For your question
may modestly reduce sleep-onset latency in older adults with insomnia, but the evidence is limited and low quality; benefit for general adults or magnesium glycinate specifically is uncertain
[see studies]
The grade (grade C) reflects the combined weight of these sources; certainty (low) is the engine's separate read on how confident to be — never the same thing.
Arab A, Rafie N, Amani R, Shirani F. The Role of Magnesium in Sleep Health: a Systematic Review of Available Literature. Biological Trace Element Research (2023) · peer-reviewed · PMID:35184264 · DOI:10.1007/s12011-022-03162-1Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis. BMC Complementary Medicine and Therapies (2021) · peer-reviewed · PMID:33865376 · DOI:10.1186/s12906-021-03297-zsmall, early-stage effect on sleep
[see studies]
The grade (grade C) reflects the combined weight of these sources; certainty (low) is the engine's separate read on how confident to be — never the same thing.
Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. Cureus (2019) · peer-reviewed · PMID:31728244 · DOI:10.7759/cureus.5797Products and quality
No commercial product or batch was assessed. Ingredient evidence does not establish that a brand has the studied form or dose, contains what its label claims, or has been independently tested.
Monitoring and follow-up
A validated personal monitoring plan is not recorded for this claim. If you act on the general evidence, decide in advance what sleep outcome matters to you and discuss unresolved safety questions with a clinician or pharmacist.
People say · Evidence shows
“Magnesium glycinate is better for sleep because it crosses the blood-brain barrier”
[explain]
popularity / assertion runs ahead of the evidence.
Belief direction is the position of the belief relative to the evidence; magnitude combines the grade-distance, whether the evidence state is unflattering to the assertion, and the claim-type penalty for speculation or marketing language (rubric: Doc 17 §2.3).
The belief never inherits the evidence's grade — by axiom B4. Speculation that outruns the data does not get credit for the data.
“Ashwagandha balances cortisol”
[explain]
popularity / assertion runs ahead of the evidence.
Belief direction is the position of the belief relative to the evidence; magnitude combines the grade-distance, whether the evidence state is unflattering to the assertion, and the claim-type penalty for speculation or marketing language (rubric: Doc 17 §2.3).
The belief never inherits the evidence's grade — by axiom B4. Speculation that outruns the data does not get credit for the data.
What the label may legally say
“Helps the body adapt to stress”
“Supports muscle and nerve function”
A legal label claim — it does not have to be proven and is not the same as evidence. We keep “people say,” “the law permits,” and “the evidence shows” visibly separate.
Trending?
magnesium — evidence and attention roughly aligned · ashwagandha — attention is ahead of the evidence
[hype vs evidence]
The hype position is the L4 read: where an intervention sits on the emerging → settled → debunked arc. A surging position with thin evidence is the classic gap; a settled position with B-grade evidence means attention and proof are roughly aligned.
What I don't know about you
- which specific SSRI and dose
- other medications or conditions
- your sleep history
Knowing these would sharpen the safety check and the answer. They're session-scoped only — never stored as a profile.
Making your decision
If you want to try the better-supported options:
- Magnesium — varied; one 8-week trial used 500 mg elemental magnesium daily, primarily older adults with insomnia; Generally fine with an SSRI; space about 2 hours apart.
Here’s what would change this advice: which specific SSRI and dose · other medications or conditions · your sleep history.
This is information to support your decision — not a verdict, and not a substitute for your clinician.
Compare other options
These are evidence comparisons for the same outcome, not personalized recommendations.
Melatonin
reduces time to fall asleep; best for circadian timing
General evidence comparison only; safety for your context has not been assessed for this alternative.
Inspect evidence5-HTP
limited evidence for sleep; serotonergic, so caution with antidepressants
General evidence comparison only; safety for your context has not been assessed for this alternative.
Inspect evidenceValerian
evidence is genuinely mixed: some low-quality trials report small improvements in subjective sleep quality, but the most rigorous reviews find no significant difference from placebo. Considered safe; not reliably effective.
General evidence comparison only; safety for your context has not been assessed for this alternative.
Inspect evidenceGlycine
small trials suggest improved subjective sleep quality and reduced next-day fatigue
General evidence comparison only; safety for your context has not been assessed for this alternative.
Inspect evidenceFull audit trail
The reasoning trace — the discrete steps the composition engine took (Doc 03, Doc 05 §5.1). Nothing was inferred outside this list.
- resolve: interventions=[mg, ash] outcome=sleep lifeStage=perimenopause meds=[ssri]
- retrieve: 2 evidence claim(s)
- contrast: 2 belief(s) with computed gaps
- safety-gate: 1 promoted; blocklist=[none]
- time: {"Magnesium":"settled","Ashwagandha":"surging"}
- law-permits: 2 label claim(s)
- clarify: safety-critical conditions unknown — asked one question
- applicability: cannot-determine (ec_mg_sleep)
- alternatives: ec_mel_sleep, ec_5htp_sleep, ec_val_sleep, ec_gly_sleep
model slice-0.1.0 · as of 2026-07-18T19:00:27.100Z